Private insurance companies say U.S. patients aren’t paying the true cost of expensive medications such as Wegovy and Zepbound, which can easily cost upwards of $1,000. Wegovy, the weight-loss medication made by Novo Nordisk, is listed at $1,349 in the U.S. but sells for a fraction of that in Europe. In the United Kingdom, it costs $92, according to evidence provided…
This article is available to Insider Pro subscribers only. Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Clinton Mora is a reporter for Trending Insurance News. He has previously worked for the Forbes. As a contributor to Trending Insurance News, Clinton covers emerging a wide range of property and casualty insurance related stories.